UAS Laboratories, The Probiotic Company Information

UAS Labs, LLC was acquired by Chr. Hansen in 2020. In December 2022, Chr. Hansen and Novozymes entered into an agreement to create a leading global biosolutions partner by combining the two companies. The goal was to unleash the full potential of biological solutions and generate significant value for all stakeholders and society. The combination was completed in January 2024 and Novonesis was born. To follow our journey to better our world with biology, visit www.linkedin.com/company/novonesis. Founded in 1979, UAS Labs, LLC delivered the highest quality, science-backed probiotics to the natural products marketplace for more than thirty years. Strictly dedicated to probiotic manufacturing, UAS was committed to designing innovative and effective formulations based on L. acidophilus DDS®-1, a strain that has been researched and tested rigorously for decades. UAS products were sold to natural products retailers, health professionals, private label customers and as ingredients to manufacturers in the U.S., Canada and over 35 other countries. The company was fully integrated from formulation through manufacturing, packaging and marketing, and adhered to the highest quality standards. UAS made significant investments to research, streamlined their operations through new technology and innovations, and introduced new products. UAS Labs, LLC, part of Novonesis Group.